Collect human breast tissues and associated clinical-pathologic data [ Time Frame: At time of diagnosis, surgery, and throughout standard care and clinical follow-up. ]

Biospecimen Retention: Samples Without DNA

Tissue from diagnostic biopsies, as well as initial or follow-up surgical procedures for the treatment or prevention of breast cancer. No extra tissue is taken, only what is left over following clinical use will be retained for banking purposes.

Estimated Enrollment:

10000

Study Start Date:

August 2001

Estimated Study Completion Date:

January 2020

Estimated Primary Completion Date:

January 2020 (Final data collection date for primary outcome measure)

Detailed Description:

OBJECTIVES:

Primary

Collect breast tissue for future research from women undergoing surgery for breast cancer.

Secondary

Create microarrays by tumor type for internal use by Specialized Program of Research Excellence.

OUTLINE: Tumor tissue is collected and analyzed to create microarrays by tumor type for future research studies.

PROJECTED ACCRUAL: A total of 1,250 patients will be accrued for this study.

Eligibility

Ages Eligible for Study:

Child, Adult, Senior

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

No

Sampling Method:

Non-Probability Sample

Study Population

Women undergoing biopsy or surgical procedures for the diagnosis, treatment, or prevention of breast cancer.

Criteria

DISEASE CHARACTERISTICS:

Undergoing surgery for breast cancer

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00898131